Sequoia Financial Advisors LLC lifted its stake in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 4.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,727 shares of the biotechnology company’s stock after buying an additional 81 shares during the period. Sequoia Financial Advisors LLC’s holdings in Axon Enterprise were worth $690,000 at the end of the most recent reporting period.
A number of other institutional investors have also added to or reduced their stakes in AXON. Argus Investors Counsel Inc. boosted its stake in Axon Enterprise by 1.1% during the third quarter. Argus Investors Counsel Inc. now owns 4,543 shares of the biotechnology company’s stock worth $1,816,000 after buying an additional 51 shares in the last quarter. Foundations Investment Advisors LLC bought a new stake in Axon Enterprise in the third quarter valued at about $221,000. Whittier Trust Co. of Nevada Inc. raised its position in Axon Enterprise by 3.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 8,290 shares of the biotechnology company’s stock worth $3,312,000 after purchasing an additional 301 shares in the last quarter. Whittier Trust Co. lifted its stake in Axon Enterprise by 5.0% during the third quarter. Whittier Trust Co. now owns 15,820 shares of the biotechnology company’s stock worth $6,321,000 after purchasing an additional 756 shares during the period. Finally, Everence Capital Management Inc. acquired a new stake in Axon Enterprise during the third quarter valued at approximately $543,000. 79.08% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Axon Enterprise
In other Axon Enterprise news, CEO Patrick W. Smith sold 80,300 shares of the company’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the completion of the sale, the chief executive officer now owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Axon Enterprise news, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $371.78, for a total value of $29,853,934.00. Following the transaction, the chief executive officer now owns 3,015,366 shares of the company’s stock, valued at approximately $1,121,052,771.48. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total value of $437,980.00. Following the transaction, the director now owns 26,259 shares of the company’s stock, valued at $11,500,916.82. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 371,172 shares of company stock valued at $137,000,162. 6.10% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
View Our Latest Research Report on AXON
Axon Enterprise Stock Up 0.3 %
NASDAQ AXON opened at $444.52 on Friday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88. Axon Enterprise, Inc. has a 52 week low of $199.29 and a 52 week high of $455.17. The stock has a market capitalization of $33.55 billion, a P/E ratio of 129.98, a price-to-earnings-growth ratio of 12.05 and a beta of 0.94. The stock has a fifty day moving average of $396.09 and a 200-day moving average of $336.52.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, topping the consensus estimate of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The firm had revenue of $504.00 million during the quarter, compared to analysts’ expectations of $478.35 million. During the same period in the previous year, the business posted $0.80 EPS. The company’s quarterly revenue was up 34.5% compared to the same quarter last year. On average, equities research analysts forecast that Axon Enterprise, Inc. will post 1.79 EPS for the current year.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
- Five stocks we like better than Axon Enterprise
- Stock Analyst Ratings and Canadian Analyst Ratings
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- What is the Euro STOXX 50 Index?
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.